SCAD Genetics: Another Strike Against the 'Healthy Heart' Myth

What They Found

Swedish researchers sequenced the exomes of 201 patients with spontaneous coronary artery dissection (SCAD) and found rare genetic variants in known SCAD-associated genes in approximately 25% of patients. SCAD predominantly affects women without traditional cardiovascular risk factors, making it a particularly insidious form of acute coronary syndrome.

Why It Matters

This study reinforces that cardiovascular risk assessment based solely on traditional metrics—cholesterol, blood pressure, smoking status—misses a significant genetic component. SCAD patients are typically young to middle-aged women who appear metabolically healthy by conventional standards, yet suffer acute coronary events due to arterial wall dissection rather than atherosclerotic plaque rupture.

The 25% prevalence of pathogenic variants suggests SCAD has a stronger genetic basis than previously recognized. This matters because current risk stratification tools like the Framingham Risk Score systematically underestimate risk in this population. Women with family histories of SCAD or connective tissue disorders may benefit from genetic screening even in the absence of traditional risk factors.

The mechanism differs fundamentally from typical coronary artery disease. Instead of gradual plaque buildup, SCAD involves spontaneous separation of arterial wall layers, creating a false lumen that can occlude coronary flow. This process appears linked to underlying connective tissue abnormalities encoded by the genetic variants identified.

What I'd Watch For

This is a preprint without peer review, and the specific genes and variants aren't detailed in the available summary. The study population is exclusively Swedish, limiting generalizability to other ethnic groups where genetic architecture may differ.

More importantly, we need functional studies showing how these variants actually predispose to arterial dissection. Finding variants is one thing—proving causation is another. The next critical study should demonstrate whether carriers of these variants have measurable differences in arterial wall structure or collagen composition.

Bottom Line

Genetic screening for SCAD variants should be considered in women with family histories of early coronary events, especially if conventional risk factors are absent. This study won't change acute management, but it should change how we think about cardiovascular risk assessment in young women.